Aurora Spine Corp.

As of June 30, 2026, Aurora Spine Corp. carries a market capitalization of 18.54M, placing it among publicly traded companies globally. Its enterprise value stands at 22.97M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Aurora Spine Corp. has 78.09M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.76, and the price-to-book ratio stands at 4.62.

As of June 30, 2026, Aurora Spine Corp. trades at an EV/EBITDA multiple of 106.76 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.92 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 22.97M versus a market cap of 18.54M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Aurora Spine Corp. maintains a current ratio of 2.25, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 123.31, indicating elevated leverage, while an interest coverage ratio of 0.98 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Aurora Spine Corp. posted a negative return on equity (ROE) of -36.03, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -11.91, reflecting losses generated across the asset base. Inventory turnover of 1.88 indicates how many times Aurora Spine Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on August 27, 2026, Aurora Spine Corp.'s stock has declined approximately 41.82% over the past 52 weeks. The 50-day moving average sits at 0.33, while the 200-day moving average is 0.41.

Over the twelve months ended June 30, 2026, Aurora Spine Corp. generated 24.90M in revenue and converted that into -1.73M in net income, yielding earnings per share of -0.02. EBITDA reached 215,162.17, while operating income came in at -1.27M.

As of June 30, 2026, Aurora Spine Corp. holds 514,653.80 in cash and equivalents against 4.94M in total debt, resulting in a net debt position of 3.62M. Total book value stands at 4.01M, with working capital of 5.21M providing operational flexibility.

Aurora Spine Corp. produced 981,038.85 in operating cash flow over the twelve months ended June 30, 2026. After subtracting -672,956.74 in capital expenditures, free cash flow totaled 308,082.11 - equivalent to 0.00 per share.

Over the twelve months ended June 30, 2026, Aurora Spine Corp. posted a gross margin of 61.61, reflecting its pricing power and cost economics. The operating margin of -5.08 and net profit margin of -6.95 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 1.63, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.88, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Aurora Spine Corp. shareholders.

As of June 30, 2026, Aurora Spine Corp. has an Altman Z-Score of -1.23, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.